WO2010062604A3 - Models of thrombotic thrombocytopenic purpura and methods of use thereof - Google Patents
Models of thrombotic thrombocytopenic purpura and methods of use thereof Download PDFInfo
- Publication number
- WO2010062604A3 WO2010062604A3 PCT/US2009/062228 US2009062228W WO2010062604A3 WO 2010062604 A3 WO2010062604 A3 WO 2010062604A3 US 2009062228 W US2009062228 W US 2009062228W WO 2010062604 A3 WO2010062604 A3 WO 2010062604A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ttp
- thrombocytopenic purpura
- methods
- thrombotic thrombocytopenic
- models
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knockout animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/054—Animals comprising random inserted nucleic acids (transgenic) inducing loss of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0325—Animal model for autoimmune diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0381—Animal model for diseases of the hematopoietic system
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09752581.0A EP2350294B1 (en) | 2008-10-27 | 2009-10-27 | Mouse models of thrombotic thrombocytopenic purpura and methods of use thereof |
ES09752581T ES2713270T3 (en) | 2008-10-27 | 2009-10-27 | Mouse models of thrombotic thrombocytopenic purpura and methods for its use |
NZ592905A NZ592905A (en) | 2008-10-27 | 2009-10-27 | Models of thrombotic thrombocytopenic purpura and methods of use thereof |
JP2011533425A JP5749649B2 (en) | 2008-10-27 | 2009-10-27 | Model of thrombotic thrombocytopenic purpura and method of use thereof |
KR1020117011998A KR101785118B1 (en) | 2008-10-27 | 2009-10-27 | Models of thrombotic thrombocytopenic purpura and methods of use thereof |
AU2009320088A AU2009320088B2 (en) | 2008-10-27 | 2009-10-27 | Models of thrombotic thrombocytopenic purpura and methods of use thereof |
EP18202001.6A EP3495488A1 (en) | 2008-10-27 | 2009-10-27 | Models of thrombotic thrombocytopenic purpura and methods of use thereof |
DK09752581.0T DK2350294T3 (en) | 2008-10-27 | 2009-10-27 | MOUSE MODELS OF TROMBOTIC TROMBOCYTPENIC PURPURA AND METHOD OF USING THEREOF |
CA2741634A CA2741634A1 (en) | 2008-10-27 | 2009-10-27 | Models of thrombotic thrombocytopenic purpura and methods of use thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10878108P | 2008-10-27 | 2008-10-27 | |
US61/108,781 | 2008-10-27 | ||
US15676809P | 2009-03-02 | 2009-03-02 | |
US61/156,768 | 2009-03-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010062604A2 WO2010062604A2 (en) | 2010-06-03 |
WO2010062604A3 true WO2010062604A3 (en) | 2010-07-22 |
Family
ID=41486481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/062228 WO2010062604A2 (en) | 2008-10-27 | 2009-10-27 | Models of thrombotic thrombocytopenic purpura and methods of use thereof |
Country Status (10)
Country | Link |
---|---|
US (2) | US9587249B2 (en) |
EP (2) | EP2350294B1 (en) |
JP (1) | JP5749649B2 (en) |
KR (1) | KR101785118B1 (en) |
AU (1) | AU2009320088B2 (en) |
CA (1) | CA2741634A1 (en) |
DK (1) | DK2350294T3 (en) |
ES (1) | ES2713270T3 (en) |
NZ (3) | NZ592905A (en) |
WO (1) | WO2010062604A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2685503T3 (en) | 2008-12-05 | 2018-10-09 | Baxalta GmbH | Methods of measuring in vivo division of Factor von Willebrand mediated by ADAMTS13 and their use |
RU2570162C1 (en) * | 2014-10-21 | 2015-12-10 | Общество с ограниченной ответственностью "АптаНова" | Method for simulating thrombus formation in mice for assessing effect of anticoagulant preparations |
US11597778B2 (en) | 2015-04-07 | 2023-03-07 | The Trustees Of The University Of Pennsylvania | Human monoclonal autoantibodies to ADAMTS13 and uses thereof |
CN115413627B (en) * | 2022-10-21 | 2023-03-24 | 首都医科大学附属北京儿童医院 | Construction method and application of animal model of abdominal anaphylactoid purpura |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008005290A2 (en) * | 2006-06-29 | 2008-01-10 | The Trustees Of Columbia University In The City Of New York | Methods for testing anti-thrombotic agents |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
US5175385A (en) * | 1987-09-03 | 1992-12-29 | Ohio University/Edison Animal Biotechnolgy Center | Virus-resistant transgenic mice |
US5175384A (en) * | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
US6821287B1 (en) | 1991-05-24 | 2004-11-23 | Advanced Cardiovascular Systems, Inc. | Multi-mode vascular catheter system |
WO1993019679A1 (en) | 1992-04-07 | 1993-10-14 | The Johns Hopkins University | A percutaneous mechanical fragmentation catheter system |
US5446143A (en) * | 1993-09-14 | 1995-08-29 | Board Of Regents, The University Of Texas System | Adipose-specific promoter region of human aromatase cytochrome P450 gene |
US6447796B1 (en) * | 1994-05-16 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
CA2175720C (en) * | 1996-05-03 | 2011-11-29 | Ian M. Penn | Bifurcated stent and method for the manufacture and delivery of same |
US6818014B2 (en) | 1995-03-01 | 2004-11-16 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US6824553B1 (en) | 1995-04-28 | 2004-11-30 | Target Therapeutics, Inc. | High performance braided catheter |
DE19632532A1 (en) * | 1996-08-13 | 1998-02-19 | Boehringer Ingelheim Int | Process for the production of mammals with defined genetic properties |
US6391032B2 (en) | 1996-08-23 | 2002-05-21 | Scimed Life Systems, Inc. | Stent delivery system having stent securement means |
AT405485B (en) * | 1997-05-28 | 1999-08-25 | Immuno Ag | A PHARMACEUTICAL PREPARATION CONTAINING THE VWF PROPEPTIDE |
US6818016B1 (en) * | 1997-06-27 | 2004-11-16 | The Regents Of The University Of Michigan | Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo |
US6827730B1 (en) * | 1998-01-13 | 2004-12-07 | Endovascular Technologies, Inc. | Reduced diameter stent/graft deployment catheter |
US6206914B1 (en) * | 1998-04-30 | 2001-03-27 | Medtronic, Inc. | Implantable system with drug-eluting cells for on-demand local drug delivery |
JP4340339B2 (en) | 1998-07-31 | 2009-10-07 | 財団法人化学及血清療法研究所 | Blood coagulation factor or blood coagulation control factor deficient model animal and method for producing the model animal |
ATE408699T1 (en) | 1999-03-10 | 2008-10-15 | Phogen Ltd | ADMINISTRATION OF NUCLEIC ACIDS AND PROTEINS TO CELLS |
US6368315B1 (en) | 1999-06-23 | 2002-04-09 | Durect Corporation | Composite drug delivery catheter |
US6829497B2 (en) * | 1999-09-21 | 2004-12-07 | Jamil Mogul | Steerable diagnostic catheters |
US6254631B1 (en) * | 1999-09-23 | 2001-07-03 | Intratherapeutics, Inc. | Stent with enhanced friction |
DE19951477A1 (en) * | 1999-10-26 | 2001-05-03 | Biotronik Mess & Therapieg | Stent |
US6827703B1 (en) * | 1999-11-24 | 2004-12-07 | Coopersurgical, Inc. | Single lumen balloon catheter apparatus |
JP4263826B2 (en) | 1999-11-26 | 2009-05-13 | テルモ株式会社 | Catheter manufacturing method and catheter |
US6254593B1 (en) | 1999-12-10 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Bifurcated stent delivery system having retractable sheath |
US6537311B1 (en) * | 1999-12-30 | 2003-03-25 | Advanced Cardiovascular Systems, Inc. | Stent designs for use in peripheral vessels |
ATE255860T1 (en) | 2000-03-03 | 2003-12-15 | Cook Inc | ENDOVASCULAR DEVICE WITH STENT |
US6818247B1 (en) | 2000-03-31 | 2004-11-16 | Advanced Cardiovascular Systems, Inc. | Ethylene vinyl alcohol-dimethyl acetamide composition and a method of coating a stent |
EP1294306A1 (en) | 2000-06-05 | 2003-03-26 | Theragenics Corporation | A device for delivering a therapeutic dosage |
US6805704B1 (en) * | 2000-06-26 | 2004-10-19 | C. R. Bard, Inc. | Intraluminal stents |
US6802857B1 (en) * | 2000-10-11 | 2004-10-12 | Uab Research Foundation | MRI stent |
US6565599B1 (en) * | 2000-12-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Hybrid stent |
US20020130430A1 (en) | 2000-12-29 | 2002-09-19 | Castor Trevor Percival | Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products |
US6821291B2 (en) * | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
US6818013B2 (en) | 2001-06-14 | 2004-11-16 | Cordis Corporation | Intravascular stent device |
US6517889B1 (en) * | 2001-11-26 | 2003-02-11 | Swaminathan Jayaraman | Process for coating a surface of a stent |
US7060498B1 (en) | 2001-11-28 | 2006-06-13 | Genta Salus Llc | Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
US7141540B2 (en) | 2001-11-30 | 2006-11-28 | Genta Salus Llc | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
US6805707B1 (en) | 2001-12-27 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Stent with improved ring and link pattern |
US20050222064A1 (en) * | 2002-02-20 | 2005-10-06 | Sirna Therapeutics, Inc. | Polycationic compositions for cellular delivery of polynucleotides |
US6802859B1 (en) | 2002-07-12 | 2004-10-12 | Endovascular Technologies, Inc. | Endovascular stent-graft with flexible bifurcation |
US6819951B2 (en) * | 2002-09-24 | 2004-11-16 | Mayo Foundation For Medical Education And Research | Peripherally inserted central catheter with continuous central venous oximetry and proximal high flow port |
WO2004048545A2 (en) * | 2002-11-26 | 2004-06-10 | University Of Massachusetts | DELIVERY OF siRNAs______________________________________________ |
JP5059411B2 (en) | 2003-12-19 | 2012-10-24 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | Cell transfection formulations of short interfering RNA, related compositions and methods of making and uses |
WO2006019430A2 (en) * | 2004-04-20 | 2006-02-23 | Nastech Pharmaceutical Company Inc. | Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
US7514530B2 (en) | 2004-04-26 | 2009-04-07 | Centre National De La Recherche Scientifique | Peptide carrier for delivering siRNA into mammalian cells |
PL1902141T3 (en) * | 2005-06-17 | 2012-12-31 | Baxalta Inc | Adamts13-comprising compositions having thrombolytic activity |
-
2009
- 2009-10-27 US US12/606,884 patent/US9587249B2/en not_active Expired - Fee Related
- 2009-10-27 EP EP09752581.0A patent/EP2350294B1/en not_active Not-in-force
- 2009-10-27 NZ NZ592905A patent/NZ592905A/en not_active IP Right Cessation
- 2009-10-27 KR KR1020117011998A patent/KR101785118B1/en active IP Right Grant
- 2009-10-27 CA CA2741634A patent/CA2741634A1/en not_active Abandoned
- 2009-10-27 AU AU2009320088A patent/AU2009320088B2/en not_active Ceased
- 2009-10-27 EP EP18202001.6A patent/EP3495488A1/en not_active Withdrawn
- 2009-10-27 JP JP2011533425A patent/JP5749649B2/en not_active Expired - Fee Related
- 2009-10-27 WO PCT/US2009/062228 patent/WO2010062604A2/en active Application Filing
- 2009-10-27 ES ES09752581T patent/ES2713270T3/en active Active
- 2009-10-27 NZ NZ609908A patent/NZ609908A/en not_active IP Right Cessation
- 2009-10-27 NZ NZ601709A patent/NZ601709A/en not_active IP Right Cessation
- 2009-10-27 DK DK09752581.0T patent/DK2350294T3/en active
-
2017
- 2017-01-24 US US15/413,873 patent/US20170196994A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008005290A2 (en) * | 2006-06-29 | 2008-01-10 | The Trustees Of Columbia University In The City Of New York | Methods for testing anti-thrombotic agents |
Non-Patent Citations (16)
Title |
---|
49th Annual Meeting of the American-Society-of-Hematology; Atlanta, GA, USA; December 08 -11, 2007 * |
ANTOINE G ET AL: "ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13", BRITISH JOURNAL OF HAEMATOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 120, no. 5, 1 March 2003 (2003-03-01), pages 821 - 824, XP002282271, ISSN: 0007-1048 * |
BANNO F, CHAUHAN AK, MIYATA T.: "The function of ADAMTS13 in thrombogenesis in vivo: insights from mutant mice.", INT J HEMATOL, vol. 91, 5 January 2010 (2010-01-05), pages 30 - 35, XP002564650 * |
BANNO F, KAMINAKA K, SOEJIMA K, KOKAME K, MIYATA T.: "Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease.", J BIOL CHEM., vol. 279, no. 29, 16 July 2004 (2004-07-16), pages 30896 - 30903, XP002564647 * |
BANNO F, KOKAME K, OKUDA T, HONDA S, MIYATA S, KATO H, TOMIYAMA Y, MIYATA T.: "Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura.", BLOOD, vol. 107, no. 8, 15 April 2007 (2007-04-15), pages 3161 - 3166, XP002564646 * |
CHAUHAN AK, MOTTO DG, LAMB CB, BERGMEIER W, DOCKAL M, PLAIMAUER B, SCHEIFLINGER F, GINSBURG D, WAGNER DD.: "Systemic antithrombotic effects of ADAMTS13.", J EXP MED., vol. 203, no. 3, 13 March 2006 (2006-03-13) - 20 March 2006 (2006-03-20), pages 767 - 776, XP002564641 * |
CHAUHAN AK, WALSH MT, ZHU G, GINSBURG D, WAGNER DD, MOTTO DG.: "The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis", BLOOD, vol. 111, no. 7, 14 December 2007 (2007-12-14) - 1 April 2008 (2008-04-01), pages 3452 - 3457, XP002564643 * |
CHAUHAN ANIL K ET AL: "The metalloprotease ADAMTS13 is a natural anti-thrombotic", 20051101, vol. 106, no. 11, 1 November 2005 (2005-11-01), pages 123A, XP009123786, ISSN: 0006-4971 * |
LAJE P, SHANG D, CAO W, NIIYA M, ENDO M, RADU A, DEROGATIS N, SCHEIFLINGER F, ZOLTICK PW, FLAKE AW, ZHENG XL.: "Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy.", BLOOD, vol. 113, no. 10, 5 March 2009 (2009-03-05), pages 2172 - 2180, XP002564649 * |
MIMURO J ET AL: "Unbalanced expression of ADAMTS13 and von Willebrand factor in mouse endotoxinemia", THROMBOSIS RESEARCH, TARRYTOWN, NY, US, vol. 122, no. 1, 1 January 2008 (2008-01-01), pages 91 - 97, XP022622413, ISSN: 0049-3848, [retrieved on 20071119] * |
MIYATA TOSHIYUKI ET AL: "Measurement of ADAMTS13 activity and inhibitors", CURRENT OPINION IN HEMATOLOGY, RAPID SCIENCE PUBLISHERS, PHILADELPHIA, PA, US, vol. 12, no. 5, 1 September 2005 (2005-09-01), pages 384 - 389, XP009123785, ISSN: 1065-6251 * |
MOTTO DG, CHAUHAN AK, ZHU G, HOMEISTER J, LAMB CB, DESCH KC, ZHANG W, TSAI HM, WAGNER DD, GINSBURG D.: "Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.", J CLIN INVEST., vol. 115, no. 10, October 2005 (2005-10-01), pages 2752 - 2761, XP002564644 * |
NIIYA M, ENDO M, SHANG D, ZOLTICK PW, MUVARAK NE, CAO W, JIN SY, SKIPWITH CG, MOTTO DG, FLAKE AW, ZHENG XL.: "Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes.", MOL THER., vol. 17, no. 1, January 2009 (2009-01-01), pages 34 - 41, XP002564648 * |
NIIYA MASAMI; ENDO MASAYTIKI; ZOLTICK PHILIP W; MUVARAK NIDAL E; MOTTO DAVID G; ALAN W FLAKE; ZHENG X LONG: "Phenotypic correction of Adamts13-deficient mice by early intra-amniotic gene transfer of lentiviral vector encoding ADAMTS13 genes", BLOOD, vol. 110, no. 11pt1, 16 November 2007 (2007-11-16), pages 66A, XP002564642 * |
PLAIMAUER BARBARA ET AL: "Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13)", BLOOD, vol. 100, no. 10, 15 November 2002 (2002-11-15), pages 3626 - 3632, XP002292631, ISSN: 0006-4971 * |
ZHOU W, BOUHASSIRA EE, TSAI HM.: "An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.", BLOOD., vol. 110, no. 3, 1 August 2007 (2007-08-01), pages 886 - 893, XP002564645 * |
Also Published As
Publication number | Publication date |
---|---|
ES2713270T3 (en) | 2019-05-20 |
JP5749649B2 (en) | 2015-07-15 |
NZ609908A (en) | 2014-07-25 |
KR101785118B1 (en) | 2017-10-12 |
US9587249B2 (en) | 2017-03-07 |
EP2350294B1 (en) | 2018-12-05 |
JP2012506707A (en) | 2012-03-22 |
CA2741634A1 (en) | 2010-06-03 |
US20100115637A1 (en) | 2010-05-06 |
DK2350294T3 (en) | 2019-03-25 |
KR20110089306A (en) | 2011-08-05 |
EP2350294A2 (en) | 2011-08-03 |
WO2010062604A2 (en) | 2010-06-03 |
AU2009320088B2 (en) | 2015-03-19 |
EP3495488A1 (en) | 2019-06-12 |
NZ601709A (en) | 2013-12-20 |
US20170196994A1 (en) | 2017-07-13 |
NZ592905A (en) | 2012-11-30 |
AU2009320088A1 (en) | 2010-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014006158A (en) | Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non- response alleles. | |
CY1121327T1 (en) | MODIFIED ANTIBODIES ANTI-IL-23P19 | |
CY1115437T1 (en) | Hydroxymethylcyclohexylamines | |
ATE541875T1 (en) | STRATEGIES FOR RELEASE OF ACTIVE INGREDIENTS USING MICELLARS AND PARTICLES | |
CY1118069T1 (en) | ANTI-BCMA ANTIBODIES | |
WO2012118750A3 (en) | Biological markers and methods for predicting response to b-cell antagonists | |
CY1121742T1 (en) | S100A4 ANTIBODIES AND THERAPEUTIC USES THEREOF | |
EA201591131A1 (en) | DNA STRUCTURE ANTIBODY AND METHOD OF THEIR APPLICATION | |
MA32190B1 (en) | Antibodies to angiopoietin 1 and angiopoietin 2 and their use | |
TW200622950A (en) | Methods of monitoring the concentration of an analyte | |
EA201071421A1 (en) | ANTI-FLT3 ANTIBODIES | |
BR112014024893A2 (en) | b cell maturation antigen-directed chimeric antigen receptors | |
EP2542581A4 (en) | Antibody specific for apolipoprotein and methods of use thereof | |
BR112013008364A2 (en) | porous mass smoking devices having a carbon particle charge and an encapsulated pressure drop | |
CO6592067A2 (en) | Elance protein cd 127 | |
MY163055A (en) | Polycyclic antagonists of lysophosphatidic acid receptors | |
MX2010008060A (en) | Humanized antibodies specific for von willebrand factor. | |
WO2010062604A3 (en) | Models of thrombotic thrombocytopenic purpura and methods of use thereof | |
EA201170636A1 (en) | Antagonists of toll-like receptor 3 | |
MA33537B1 (en) | Antibodies against human cdcp1 | |
AR073459A1 (en) | COMPOSITIONS OF VARIABLE DOMAINS OF MONOVALENT ANTIBODIES FOR THE UNION OF CD28 AND METHODS OF USE | |
WO2012010974A3 (en) | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia | |
CY1112322T1 (en) | SPIRAL PRODUCERS (5.5) UNDERWATER | |
MX2015000754A (en) | Human btnl3 proteins, nucleic acids, and antibodies and uses thereof. | |
CY1116216T1 (en) | METHOD OF THERAPEUTIC DISEASE THERAPY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09752581 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011533425 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2741634 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009320088 Country of ref document: AU Ref document number: 592905 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009752581 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20117011998 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2009320088 Country of ref document: AU Date of ref document: 20091027 Kind code of ref document: A |